Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Microbiol Infect ; 10(9): 804-10, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15355411

ABSTRACT

Antimicrobial susceptibility testing was performed on 3,627 isolates of Escherichia coli and 180 isolates of Shigella spp. collected in rural locations from 875 Egyptian children with diarrhoea between 1995 and 2000. The cumulative rates of resistance for E. coli and Shigella spp. were high (respectively, 68.2% and 54.8% for ampicillin, 24.2% and 23.5% for ampicillin-sulbactam, 57.2% and 42.5% for trimethoprim-sulphamethoxazole, and 50.9% and 75.4% for tetracycline). Non-enterotoxigenic E. coli (NETEC) isolates had a consistently higher level of antimicrobial resistance than did enterotoxigenic E. coli (ETEC) isolates. Trend testing showed significant decreases in resistance to ampicillin, ampicillin-sulbactam and tetracycline among all E. coli isolates. Increasing rates of resistance were observed for trimethoprim-sulphamethoxazole in ETEC isolates and Shigella spp., but not in NETEC isolates. Low levels of resistance were observed for all other antimicrobial agents tested. Overall, high levels, but decreasing trends, of resistance to commonly used antimicrobial agents were detected among isolates of E. coli and Shigella spp. from children in rural Egypt.


Subject(s)
Anti-Bacterial Agents/pharmacology , Diarrhea/microbiology , Escherichia coli/drug effects , Rural Population , Shigella/drug effects , Child , Child, Preschool , Drug Resistance, Bacterial , Dysentery, Bacillary/microbiology , Egypt , Enterotoxins/metabolism , Escherichia coli/immunology , Escherichia coli/isolation & purification , Escherichia coli Infections/microbiology , Escherichia coli Infections/prevention & control , Escherichia coli Vaccines/administration & dosage , Female , Humans , Infant , Male , Microbial Sensitivity Tests , Shigella/isolation & purification
2.
Pediatrics ; 104(1): e3, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10390289

ABSTRACT

BACKGROUND: Initiation of breastfeeding shortly after delivery may enhance breastfeeding's protective effect against diarrhea because of the protective properties of human colostrum contained in early breast milk. OBJECTIVE: To evaluate whether initiation of breastfeeding within the first 3 days of life, when breast milk contains colostrum, was associated with a lower rate of diarrhea in rural Egyptian infants during the first 6 months of life. METHODS: Infants initially breastfed (n = 198) were monitored prospectively with twice-weekly home visits to ascertain dietary practices and diarrheal illnesses. RESULTS: The burden of diarrhea during the first 6 months of life in the cohort was high: seven episodes per child-year of follow-up. Only 151 (76%) infants initiated breastfeeding during the first 3 days of life ("early initiation"). Infants in whom breastfeeding was initiated early had a 26% (95% CI: 2%,44%) lower rate of diarrhea than those initiated late. The protective association between early initiation and diarrhea was independent of the pattern of postinitiation dietary practices and was evident throughout the first 6 months of life. CONCLUSIONS: Early initiation of breastfeeding was associated with a marked reduction of the rate of diarrhea throughout the first 6 months of life, possibly because of the salutary effects of human colostrum. These data highlight the need for interventions to encourage early initiation of breastfeeding in less developed settings.


Subject(s)
Breast Feeding , Diarrhea, Infantile/prevention & control , Breast Feeding/statistics & numerical data , Cohort Studies , Colostrum/immunology , Diarrhea, Infantile/epidemiology , Egypt , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Multivariate Analysis , Rural Health , Survival Analysis , Time Factors
3.
J Clin Microbiol ; 37(3): 873-4, 1999 Mar.
Article in English | MEDLINE | ID: mdl-9986881

ABSTRACT

In a population-based study of diarrhea in rural, northern Egypt, 60 Shigella flexneri strains were identified, of which 10 could not be definitively serotyped. Serological analysis with commercial reagents suggested that they were serotype 1, but the strains failed to react with subserotype 1a- or 1b-specific antibodies. All 10 strains reacted with MASF 1c, a monoclonal antibody specific for a provisional S. flexneri subserotype, 1c, first identified in Bangladesh and not previously detected outside of that region. Our results show that S. flexneri subserotype 1c is not unique to Bangladesh and that the inability to detect it may reflect both the limited use of suitable screening methods and the rarity of this subserotype.


Subject(s)
Diarrhea/microbiology , Dysentery, Bacillary/diagnosis , Shigella flexneri/classification , Antibodies, Bacterial/analysis , Antibodies, Monoclonal , Antigens, Bacterial/immunology , Dysentery, Bacillary/immunology , Dysentery, Bacillary/microbiology , Egypt , Feces/microbiology , Humans , Reagent Kits, Diagnostic , Rural Population , Serotyping , Shigella flexneri/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...